Global Nexus Network

.Though Alkeus Pharmaceuticals’ oral eye condition property failed to considerably lower geographic atrophy (GA) sore growth, the biotech is citing “clinically significant” outcomes and a

.While the biotech investment scene in Europe has actually slowed somewhat observing a COVID-19 funding boom in 2021, a brand-new document coming from PitchBook proposes

.Merck &amp Co. has actually promptly redeemed some of the costs of its own Weapon Therapeutics buyout, attracting $170 million ahead of time through combining

.Cullinan Therapy was actually blown away sufficient with Port BioMed’s bispecific invulnerable reactor that it surrendered $25 thousand in 2015 for the drug’s USA civil

.Welcome to this week’s Chutes &amp Ladders, our summary of significant management hirings, firings and also retirings across the market. Please send the compliment– or

.Compass Pathways’ adventure to phase 3 psychedelic clinical depression data is actually taking a lot longer than anticipated. With the tests overrunning by months, the

.Tip has actually reported phase 3 information on its own near-approval pain medicine applicant suzetrigine, shedding light on how the non-opioid pain reliever mixes along

.Cognition Therapies’ stage 2 SHINE trial has actually taken a few of the appeal off the Alzheimer’s illness drug candidate CT1812. The oral sigma-2 villain

.Invite to this week’s Chutes &amp Ladders, our roundup of notable management hirings, firings and retirings throughout the industry. Satisfy send the good word– or

.Mandarin the hormone insulin creator Gan &amp Lee Pharmaceuticals is actually wading into the excessive weight globe along with an injectable GLP-1 agonist that beat